Is HLA matching worthwhile in pancreatic transplantation?
Hopt
U T
UT
Department of Surgery, University of Tübingen, Germany.
Büsing
M
M
Schareck
W
W
Pfeffer
F
F
Irkin
I
I
Becker
H D
HD
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone